We're embracing a comprehensive strategy to create effective treatments for Pyruvate Carboxylase Deficiency, with gene therapy taking forefront in our initial approach. Our efforts represent fundamental building blocks, paving the way for advancing research and treatments that will have positive impact on countless individuals affected by rare diseases globally.
The Kiana Research Foundation supports research toward an effective treatment and a cure for Pyruvate Carboxylase Deficiency. Pyruvate carboxylase deficiency is a rare condition, with an estimated incidence of 1 in 250,000 births worldwide. Pyruvate carboxylase deficiency is… Read More
Learn MoreWe are honored to announce our partnership with Dr. Miguel Sena-Esteves for the research and investigation of AAV gene-therapy for Pyruvate Carboxylase Deficiency. In the initial pre-clinical phase of our project, we will commence by synthesizing AAV vectors… Read More
Learn MoreOur children are not just rare disease patients. We are loving families. We have hopes and dreams like everyone else Every 30 minutes, a child is born who will develop a mitochondrial disorder by age 10. Due to… Read More
Learn More